The μ-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist

European Journal of Pharmacology

Volumn 545, Issue 2-3, 2006, Pages 147-152

  Zhang, Jiaping ^a   Frassetto, Andrea ^a   Huang, Ruey Ruey C ^a   Lao, Julie Z ^a   Pasternak, Alexander ^a   Wang, Sheng ping ^a   Metzger, Joseph M ^a   Strack, Alison M ^a   Fong, Tung M ^a   Chen, Richard Z ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Body weight; Food intake; Knockout mice; Opioid receptor antagonist

Indexed keywords

6 [4 [[(3 METHYLBUTYL)AMINO]METHYL]PHENOXY]NICOTINAMIDE; ANOREXIGENIC AGENT; CYCLIC AMP; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANOREXIA; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CELL CULTURE; CLONING; CONTROLLED STUDY; DOSE RESPONSE; FEEDING; FOOD INTAKE; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

ANIMALS; APPETITE DEPRESSANTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HUMANS; MALE; MICE; MICE, INBRED C57BL; NARCOTIC ANTAGONISTS; RATS; RECEPTORS, OPIOID, MU;

EID: 33747351652     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.069     Document Type: Article

References (29)

1. Arjune D., Bowen W.D., and Bodnar R.J. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor. Pharmacol. Biochem. Behav. 39 (1991) 429-436
2. Barton C., York D.A., and Bray G.A. Opioid receptor subtype control of galanin-induced feeding. Peptides 17 (1996) 237-240
3. Bhushan R.G., Sharma S.K., Xie Z., Daniels D.J., and Portoghese P.S. A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J. Med. Chem. 47 (2004) 2969-2972
4. Billington C.J., Morley J.E., Levine A.S., Wright F., and Seal U.S. Naloxone induced suppression of feeding in tigers. Physiol. Behav. 34 (1985) 641-643
5. Bodnar R.J. Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25 (2004) 697-725
6. Daniels D.J., Kulkarni A., Xie Z., Bhushan R.G., and Portoghese P.S. A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. J. Med. Chem. 48 (2005) 1713-1716
7. Daniels D.J., Lenard N.R., Etienne C.L., Law P.Y., Roerig S.C., and Portoghese P.S. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19208-19213
8. de Zwaan M., and Mitchell J.E. Opiate antagonists and eating behavior in humans: a review. J. Clin. Pharmacol. 32 (1992) 1060-1072
9. Deviche P., and Wohland A. Opiate antagonists stereoselectively attenuate the consumption of food but not of water by pigeons. Pharmacol. Biochem. Behav. 21 (1984) 507-512
10. Eguchi M. Recent advances in selective opioid receptor agonists and antagonists. Med. Res. Rev. 24 (2004) 182-212
11. Ferguson-Segall M., Flynn J.J., Walker J., and Margules D.L. Increased immunoreactive dynorphin and leu-enkephalin in posterior pituitary of obese mice (ob/ob) and super-sensitivity to drugs that act at kappa receptors. Life Sci. 31 (1982) 2233-2236
12. Glass M.J., Billington C.J., and Levine A.S. Opioids and food intake: distributed functional neural pathways?. Neuropeptides 33 (1999) 360-368
13. Glass M.J., Briggs J.E., Billington C.J., Kotz C.M., and Levine A.S. Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression. Am. J. Physiol., Regul. Integr. Comp. Physiol. 283 (2002) R161-R167
14. Hadjimarkou M.M., Singh A., Kandov Y., Israel Y., Pan Y.X., Rossi G.C., Pasternak G.W., and Bodnar R.J. Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats. J. Pharmacol. Exp. Ther. 311 (2004) 1188-1202
15. Herve C., and Fellmann D. Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation. Neuropeptides 31 (1997) 237-242
16. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
17. Koch J.E., and Bodnar R.J. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Brain Res. 657 (1994) 191-201
18. Kotz C.M., Grace M.K., Billington C.J., and Levine A.S. The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res. 631 (1993) 325-328
19. Margules D.L., Moisset B., Lewis M.J., Shibuya H., and Pert C.B. beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science 202 (1978) 988-991
20. Marks-Kaufman R., Balmagiya T., and Gross E. Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol. Biochem. Behav. 20 (1984) 911-916
21. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
22. Reid L.D. Endogenous opioid peptides and regulation of drinking and feeding. Am. J. Clin. Nutr. 42 (1985) 1099-1132
23. Sanger D.J., and McCarthy P.S. Increased food and water intake produced in rats by opiate receptor agonists. Psychopharmacology (Berl) 74 (1981) 217-220
24. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., Chang A., Czick M.E., Unterwald E.M., Pasternak G.W., and Pintar J.E. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2 (1999) 151-156
25. Shaw W.N. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants. Pharmacol. Biochem. Behav. 46 (1993) 653-659
26. Statnick M.A., Tinsley F.C., Eastwood B.J., Suter T.M., Mitch C.H., and Heiman M.L. Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 (2003) R1399-R1408
27. Tabarin A., Chaves Y.D., Carmona Mdel C., Catargi B., Zorrilla E.P., Roberts A.J., Coscina D.V., Rousset S., Redonnet A., Parker G.C., Inoue K., Ricquier D., Penicaud L., Kieffer B.L., and Koob G.F. Resistance to diet-induced obesity in {micro}-opioid receptor-deficient mice: evidence for a "Thrifty Genes". Diabetes 54 (2005) 3510-3516
28. Welch C.C., Kim E.M., Grace M.K., Billington C.J., and Levine A.S. Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels. Brain Res. 721 (1996) 126-131
29. Yeomans M.R., and Gray R.W. Opioid peptides and the control of human ingestive behaviour. Neurosci. Biobehav. Rev. 26 (2002) 713-728